)
)
)
Sidocel, Inc.
Sidocel focuses on the development of Tri-Specific Nanobody T-Cell Engagers (NTCEs) and in vivo CAR-T therapies to advance nanobody-powered next-generation immunotherapies for the treatment of solid tumors and autoimmune diseases.
Address
PhiladelphiaPennsylvania
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)